Tesla has introduced a significant upgrade to its humanoid robot, Optimus, featuring enhanced hands with improved dexterity. This enhancement aligns with Neuralink’s recent FDA approval for its CONVOY Study, which will test the Brain-to-Computer (BCI) N1 Implant with assistive robotic arms, such as those of the Optimus bot.
Neuralink’s CONVOY Study
The CONVOY Study aims to extend BCI control using the N1 Implant to an investigational assistive robotic arm. This is a crucial step towards restoring not only digital freedom but also physical freedom for individuals with paralysis or other motor disorders.
Tesla Optimus’ New Hands
The latest update from Tesla Optimus humorously stated, “Got a new hand for Black Friday,” showcasing the robot’s capability to catch a tennis ball with its upgraded hand. CEO Elon Musk had previously indicated plans to enhance Optimus’ hands to achieve 22 degrees of freedom, nearing the 27 degrees found in human hands.
Autonomous Navigation and Interaction
The unveiling of the new hand upgrade comes at a time when Tesla is making strides in autonomous navigation and interaction capabilities. In October, Tesla showcased Optimus’ ability to autonomously navigate a factory, avoid obstacles, and interact with humans by handing over snacks and drinks upon request.
Challenges and Future Plans
Despite the challenges in refining Optimus’ design for easier manufacturing and establishing a complex supply chain for mass production, Musk remains optimistic about the long-term economic potential of humanoid robots driven by artificial general intelligence. Tesla is actively seeking top talent to enhance software for the teleoperation of its robotaxis and Optimus robots, aiming to develop low-latency, reliable data streaming solutions for real-world applications.
Price Action
Tesla stock closed at $332.89 on Wednesday, down 1.6% for the day. In after-hours trading, the stock increased slightly by 0.5%. Year to date, Tesla’s stock has gained 34%.
Analyst Ratings
Analysts have a consensus rating of “Neutral” on the Tesla stock. The highest price target is $400, while the consensus price target is 232.20, implying a 30% downside.